Takeda Pharmaceutical Co., Ltd. (TKPHF)
41.15
-0.07
(-0.17%)
USD |
OTCM |
Oct 27, 16:00
Takeda Pharmaceutical Enterprise Value : 92.59B for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 92.59B |
| October 26, 2026 | 92.70B |
| October 23, 2026 | 92.70B |
| October 22, 2026 | 90.46B |
| October 21, 2026 | 90.46B |
| October 20, 2026 | 90.67B |
| October 19, 2026 | 89.20B |
| October 16, 2026 | 88.62B |
| October 15, 2026 | 88.62B |
| October 14, 2026 | 81.06B |
| October 13, 2026 | 81.06B |
| October 12, 2026 | 81.06B |
| October 09, 2026 | 81.06B |
| October 08, 2026 | 81.06B |
| October 07, 2026 | 81.06B |
| October 06, 2026 | 81.06B |
| October 05, 2026 | 84.06B |
| October 02, 2026 | 85.68B |
| October 01, 2026 | 85.64B |
| September 30, 2026 | 86.04B |
| September 29, 2026 | 86.04B |
| September 28, 2026 | 86.04B |
| September 25, 2026 | 86.04B |
| September 24, 2026 | 86.04B |
| September 23, 2026 | 87.62B |
| Date | Value |
|---|---|
| September 22, 2026 | 87.62B |
| September 21, 2026 | 87.62B |
| September 18, 2026 | 87.62B |
| September 17, 2026 | 87.62B |
| September 16, 2026 | 84.76B |
| September 15, 2026 | 84.76B |
| September 14, 2026 | 84.76B |
| September 11, 2026 | 84.76B |
| September 10, 2026 | 83.41B |
| September 09, 2026 | 84.66B |
| September 08, 2026 | 83.57B |
| September 04, 2026 | 85.72B |
| September 03, 2026 | 81.64B |
| September 02, 2026 | 81.64B |
| September 01, 2026 | 81.64B |
| August 31, 2026 | 81.64B |
| August 28, 2026 | 85.44B |
| August 27, 2026 | 85.44B |
| August 26, 2026 | 85.44B |
| August 25, 2026 | 87.43B |
| August 24, 2026 | 85.15B |
| August 21, 2026 | 85.15B |
| August 20, 2026 | 85.15B |
| August 19, 2026 | 81.29B |
| August 18, 2026 | 81.29B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Daiichi Sankyo Co., Ltd. | 29.10B |
| Eisai Co., Ltd. | 9.000B |
| Chugai Pharmaceutical Co., Ltd. | 66.97B |
| Santen Pharmaceutical Co., Ltd. | 3.297B |
| Ono Pharmaceutical Co., Ltd. | 6.642B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 710.72M |
| Revenue (Quarterly) | 7.655B |
| Total Expenses (Quarterly) | 6.945B |
| EPS Diluted (Quarterly) | 0.4427 |
| Gross Profit Margin (Quarterly) | 57.57% |
| Profit Margin (Quarterly) | 9.28% |
| Earnings Yield | -1.64% |
| Operating Earnings Yield | 6.98% |
| Normalized Earnings Yield | -0.8719 |